Immuron Limited (IMRN)
NASDAQ: IMRN · Real-Time Price · USD
1.130
-0.080 (-6.61%)
Jul 20, 2026, 4:00 PM EDT - Market closed
Immuron Market Cap
Immuron has a market cap or net worth of $9.15 million as of July 21, 2026. Its market cap has decreased by -5.70% in one year.
Market Cap
9.15M
Enterprise Value
2.29M
1-Year Change
-5.70%
Ranking
Category
Stock Price
$1.13
ChartMarket Cap Chart
Since June 9, 2017, Immuron's market cap has decreased from $28.10M to $9.15M, a decrease of -67.45%. That is a compound annual growth rate of -11.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 9.15M | 103.26% |
| Dec 31, 2025 | 4.50M | -53.61% |
| Dec 31, 2024 | 9.70M | -9.35% |
| Dec 29, 2023 | 10.70M | -9.32% |
| Dec 30, 2022 | 11.80M | -16.90% |
| Dec 31, 2021 | 14.20M | -50.00% |
| Dec 31, 2020 | 28.40M | 91.89% |
| Dec 31, 2019 | 14.80M | -28.50% |
| Dec 31, 2018 | 20.70M | 20.35% |
| Dec 29, 2017 | 17.20M | -38.79% |
| Jun 9, 2017 | 28.10M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chemomab Therapeutics | 11.23M |
| Moleculin Biotech | 11.21M |
| Theriva Biologics | 11.06M |
| Exicure | 10.71M |
| Traws Pharma | 10.17M |
| Vistagen Therapeutics | 9.40M |
| BioCardia | 9.39M |
| Curis | 9.02M |